Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992

By Cotterill S.J.   Pearson A.D.J.   Pritchard J.   Foot A.B.M.   Roald B.   Kohler J.A.   Imeson J.  

European Journal of Cancer, Vol. 36, Iss. 7, 2000-05 ,pp. : 901-908

Elsevier

Access to resources Recommend Favorite

Feasibility of implementing molecular‐guided therapy for the treatment of patients with relapsed or refractory neuroblastoma

By  

Cancer Medicine, Vol. 4, Iss. 6, 2015-06 ,pp. : 871-886

John Wiley & Sons Inc

Access to resources Recommend Favorite

The contribution of molecular epidemiology to the identification of human carcinogens: current status and future perspectives

By Boffetta P.   Islami F.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 901-908

Oxford University Press

Access to resources Recommend Favorite

Molecular characterization and classification of neuroblastoma

By Oberthuer Andréé   Theissen Jessica   Westermann Frank   Hero Barbara   Fischer Matthias  

Future Oncology, Vol. 5, Iss. 5, 2009-06 ,pp. : 625-639

Future Medicine

Access to resources Recommend Favorite

Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors

By Cauley Jane   Song Jingli   Dowsett Sherie   Mershon John   Cummings Steven  

Breast Cancer Research and Treatment, Vol. 102, Iss. 2, 2007-04 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite